# Product Requirements Document (PRD)
# Public Relations AI Agent for Drug Sentiment Analysis

---

## Document Information

| Field | Value                                                             |
|-------|-------------------------------------------------------------------|
| **Product Name** | PR Sentiment Intelligence Agent                                   |
| **Version** | 1.0                                                               |
| **Date** | June 2025                                                         |
| **Author** | Ritik Khatwani                                                    |
| **Status** | Draft                                                             |
| **Stakeholders** | PR Directors, Medical Affairs, Brand Managers, Regulatory Affairs |

---

## 1. Executive Summary

### 1.1 Product Overview
The PR Sentiment Intelligence Agent is an AI-powered solution that proactively monitors and analyzes patient sentiment on Drugs.com to help pharmaceutical companies understand real-world drug experiences, identify emerging issues, and improve patient outcomes through data-driven insights.

### 1.2 Business Objectives
- **Primary**: Provide early warning system for adverse events and emerging patient concerns
- **Secondary**: Optimize patient experience based on real feedback
- **Tertiary**: Support regulatory compliance through sentiment tracking

### 1.3 Success Criteria
- Detect PR risks effectively through batch analysis
- Achieve >90% sentiment classification accuracy
- Generate actionable insights leading to measurable patient experience improvements

---

## 2. Problem Statement

### 2.1 Current State
Pharmaceutical companies currently face several challenges in monitoring patient sentiment:
- **Manual Analysis**: Time-intensive review of patient feedback
- **Limited Context**: Generic sentiment tools lack medical understanding
- **Compliance Gaps**: Difficulty tracking sentiment for regulatory purposes
- **Fragmented Insights**: No centralized view of patient experience

### 2.2 Pain Points
- **Safety Signal Detection**: Manual processes miss early warning signs
- **Patient Experience**: Limited understanding of real-world drug impact
- **Regulatory Reporting**: Difficulty aggregating sentiment for compliance
- **Resource Allocation**: Inefficient use of PR and medical affairs teams

### 2.3 Opportunity
- **Patient Outcomes**: Better understanding leads to improved drug experiences

---

## 3. Product Vision & Strategy

### 3.1 Vision Statement
"Transform pharmaceutical companies from reactive to proactive in understanding and responding to patient experiences through AI-powered sentiment intelligence."

### 3.2 Product Strategy
- **Build**: AI-native solution using Amazon Bedrock InlineAgents
- **Focus**: Patient-centric sentiment analysis with medical context
- **Scale**: Start with single-drug monitoring, expand to portfolio-wide intelligence
- **Differentiate**: Medical expertise and compliance-first design

### 3.3 Core Value Proposition
Transform unstructured patient reviews into actionable intelligence for:
- **Early warning system** for adverse events or emerging concerns
- **Patient experience optimization** based on real feedback
- **Regulatory compliance** support with sentiment tracking

---

## 4. Target Users & Use Cases

### 4.1 Primary Users

#### 4.1.1 PR Directors
- **Role**: Strategic reputation management
- **Goals**: Prevent PR crises, maintain positive brand perception
- **Pain Points**: Late detection of issues, manual monitoring processes
- **Success Metrics**: Crisis prevention rate, response time improvement

### 4.2 Use Case Scenarios

#### 4.2.1 Launch Monitoring
**Scenario**: New drug launch sentiment tracking
- **Trigger**: Product launch date
- **Response**: Periodic sentiment reports and trend analysis
- **Outcome**: Market reception insights

#### 4.2.2 Patient Advocacy
**Scenario**: Understanding patient access challenges
- **Trigger**: Recurring mentions of cost/access issues
- **Response**: Patient experience report with recommendations
- **Outcome**: Improved patient support programs

---

## 5. Functional Requirements

### 5.1 Core Features

#### 5.1.1 Data Collection & Processing
**Priority**: P0 (Must Have)

**Requirements**:
- **FR-001**: System shall scrape patient reviews from Drugs.com
- **FR-002**: System shall respect rate limits and ethical scraping practices
- **FR-003**: System shall handle a single drug name at a time

**Acceptance Criteria**:
- Successfully collect available reviews for specified drug
- Zero violations of platform terms of service

#### 5.1.2 Sentiment Analysis Engine
**Priority**: P0 (Must Have)

**Requirements**:
- **FR-006**: System shall classify sentiment across 5 dimensions:
  - Overall Sentiment (Positive, Negative, Neutral, Mixed)
  - Efficacy Sentiment (Effective, Ineffective, Partial)
  - Side Effect Sentiment (Tolerable, Concerning, Severe)
  - Experience Sentiment (Satisfied, Neutral, Dissatisfied)
  - Recommendation Likelihood (Would/Wouldn't recommend)
- **FR-007**: System shall achieve >90% classification accuracy
- **FR-008**: System shall provide confidence scores for classifications
- **FR-009**: System shall handle medical terminology and context

**Acceptance Criteria**:
- Sentiment accuracy validated against expert annotations
- Medical context properly interpreted in 95% of cases

#### 5.1.3 Risk Detection & Analysis
**Priority**: P0 (Must Have)

**Requirements**:
- **FR-010**: System shall detect 5 risk categories:
  - Safety Signals (unusual adverse event patterns)
  - Efficacy Concerns (declining effectiveness reports)
  - Viral Negative Reviews (high-engagement negative content)
  - Patient Experience Issues (access, cost, usability)
- **FR-011**: System shall provide risk severity scoring (1-10 scale)
- **FR-012**: System shall generate risk assessment reports

**Acceptance Criteria**:
- Risk detection accuracy >95% for critical issues
- <5% false positive rate for critical alerts
- Risk scores validated against historical incidents

### 5.2 Advanced Features

#### 5.2.1 Multi-Agent Collaboration
**Priority**: P1 (Should Have)

**Requirements**:
- **FR-018**: System shall implement supervisor-collaborator agent architecture
- **FR-019**: System shall coordinate 5 specialized agents:
  - Data Collection Agent
  - Sentiment Analysis Agent
  - Risk Assessment Agent
  - Patient Experience Agent
- **FR-020**: System shall optimize agent task distribution
- **FR-021**: System shall provide agent performance monitoring

**Acceptance Criteria**:
- Multi-agent system processes tasks efficiently
- Agent coordination reduces overall processing time


---

## 6. Appendices

### 6.1 Glossary

| Term | Definition |
|------|------------|
| **Adverse Event** | Any untoward medical occurrence associated with drug use |
| **Batch Processing** | Processing data in discrete chunks rather than continuously |
| **InlineAgent** | Amazon Bedrock agent configured and invoked dynamically at runtime |
| **Multi-Agent Collaboration** | Architecture where multiple AI agents work together on complex tasks |
| **Pharmacovigilance** | Science of monitoring drug safety and preventing adverse effects |
| **Safety Signal** | Information suggesting a new potentially causal association between drug and adverse event |
| **Sentiment Analysis** | Computational study of opinions, sentiments, and emotions in text |

